PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-77

  1. 1,567 Posts.
    lightbulb Created with Sketch. 625
    @39KP Agree especially the bit about a cheap bet for BP. Is it any coincidence that we are recently touting our statistical work with reduced participant numbers and still a probability of success of >98%. That seems like a very high success rate that derisks participation in the trial for a piece of the rather large upside.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.